Text to be removed highlighted in red.
1 New Paragraph; Office of Professional Licensure and Certification; Board Subcommittees. Amend RSA 310:2 by inserting after paragraph III the following new paragraph:
IV. Any board listed in this section is authorized to establish subcommittees as it deems necessary.
2 Optometry; Definitions. Amend RSA 327:1, III(c)-(m) to read as follows:
(c) Miotic agents approved pursuant to RSA 327:6-a, VI.
(d) Antibiotics, sulfonomides, and combinations thereof, which are topically applied or orally administered to treat or alleviate the effects of disease or abnormal conditions of the human eye, adnexa, and eyelids, or structures posterior to the iris, approved pursuant to RSA 327:6-a, VI.
(e) Anti-allergy medications, including but not limited to antihistamines, decongestants, and mast-cell stabilizers which are topically applied.
(f) Anesthetics and dyes which are topically applied.
(g) Ocular lubricants and hypertonic agents which are topically applied.
(h) Orally administered analgesic agents used for the purpose of alleviating pain caused by a disease or abnormal condition of the human eye or eyelid, or structures posterior to the iris. This may include class III and IV controlled substances approved pursuant to RSA 327:6-a, VI and included in the formulary.
(i) Other pharmaceutical agents, any solely diagnostic agents, and diagnostic agents combined with pharmaceutical agents as defined in this paragraph and as approved pursuant to RSA 327:6-a, VI.
(j) Non-steroidal anti-inflammatory agents approved pursuant to RSA 327:6-a, VI.
(k) Anti-glaucoma agents provided that an optometrist may dispense or prescribe such agents if the optometrist has met the requirements of RSA 327:6-c.
(l) Corticosteroids which are topically applied, as approved by the board.
(m) Antivirals which are approved pursuant to RSA 327:6-a, VI.
3 Repeal. The following are repealed:
I. RSA 309-B:4, VI(h), relative to board of accountancy rulemaking on administrative fines.
II. RSA 327:6-a, VI, relative to authority for the board to modify the list of approved pharmaceuticals for use by optometrists.
4 Effective Date. This act shall take effect 60 days after its passage.
Text to be added highlighted in green.
1 New Paragraph; Office of Professional Licensure and Certification; Board Subcommittees. Amend RSA 310:2 by inserting after paragraph III the following new paragraph:
IV. Any board listed in this section is authorized to establish subcommittees as it deems necessary.
2 Optometry; Definitions. Amend RSA 327:1, III(c)-(m) to read as follows:
(c) Miotic agents .
(d) Antibiotics, sulfonomides, and combinations thereof, which are topically applied or orally administered to treat or alleviate the effects of disease or abnormal conditions of the human eye, adnexa, and eyelids, or structures posterior to the iris.
(e) Anti-allergy medications, including but not limited to antihistamines, decongestants, and mast-cell stabilizers which are topically applied.
(f) Anesthetics and dyes which are topically applied.
(g) Ocular lubricants and hypertonic agents which are topically applied.
(h) Orally administered analgesic agents used for the purpose of alleviating pain caused by a disease or abnormal condition of the human eye or eyelid, or structures posterior to the iris. This may include class III and IV controlled substances included in the formulary.
(i) Other pharmaceutical agents, any solely diagnostic agents, and diagnostic agents combined with pharmaceutical agents as defined in this paragraph .
(j) Non-steroidal anti-inflammatory agents .
(k) Anti-glaucoma agents provided that an optometrist may dispense or prescribe such agents if the optometrist has met the requirements of RSA 327:6-c.
(l) Corticosteroids which are topically applied, as approved by the board.
(m) Antivirals .
3 Repeal. The following are repealed:
I. RSA 309-B:4, VI(h), relative to board of accountancy rulemaking on administrative fines.
II. RSA 327:6-a, VI, relative to authority for the board to modify the list of approved pharmaceuticals for use by optometrists.
4 Effective Date. This act shall take effect 60 days after its passage.